chrysophanic acid has been researched along with Cirrhosis, Liver in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, ML; Chen, YR; Chiu, V; Hsieh, PC; Huang, CY; Huang, SJ; Kuo, CY; Liu, CT; Tsai, FM; Tzeng, IS | 1 |
1 other study(ies) available for chrysophanic acid and Cirrhosis, Liver
| Article | Year |
|---|---|
Chrysophanol attenuates hepatitis B virus X protein-induced hepatic stellate cell fibrosis by regulating endoplasmic reticulum stress and ferroptosis.
Topics: Animals; Anthraquinones; Cell Line; Endoplasmic Reticulum Stress; Ferroptosis; Fibrosis; Hepatic Stellate Cells; Liver Cirrhosis; Phytotherapy; Rats; Reactive Oxygen Species; Trans-Activators; Viral Regulatory and Accessory Proteins | 2020 |